12 Healthcare Dividend Stocks With Highest Short Float Ratio

The healthcare sector is a major business. Within the stock markets there are 551 companies linked to the sector with a total market capitalization of USD 40.4 trillion. The average sector yield amounts to 3.93 percent and the average P/E ratio is 22.31.

I screened the sector by dividend stocks with the highest amount of short selling stocks, measured by the short float ratio. The ratio shows how many stocks are shorted by investors. Companies with a high ratio of short float have a little upside potential if investors need to close their short position. Twelve dividend stocks from the healthcare sector have a short float ratio of more than 5 percent and six are recommended to buy.

Herbalife (NYSE:HLF) has a market capitalization of $5.16 billion. The company employs 5,100 people, generates revenues of $3,454.54 million and has a net income of $412.58 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $634.12 million. Because of these figures, the EBITDA margin is 18.36 percent (operating margin 16.28 percent and the net profit margin finally 11.94 percent). 

Financial Analysis: The total debt representing 14.08 percent of the company’s assets and the total debt in relation to the equity amounts to 36.35 percent. Due to the financial situation, a return on equity of 78.78 percent was realized. Twelve trailing months earnings per share reached a value of $3.50. Last fiscal year, the company paid $0.73 in form of dividends to shareholders. The stock has a short float of 5.49 percent.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 12.64, P/S ratio 1.51 and P/B ratio 9.26. Dividend Yield: 2.68 percent. The beta ratio is 1.72.






STERIS (NYSE:STE) has a market capitalization of $1.67 billion. The company employs 5,000 people, generates revenues of $1,406.81 million and has a net income of $136.12 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $222.32 million. Because of these figures, the EBITDA margin is 15.80 percent (operating margin 15.80 percent and the net profit margin finally 9.68 percent).

Financial Analysis: The total debt representing 14.94 percent of the company’s assets and the total debt in relation to the equity amounts to 25.53 percent. Due to the financial situation, a return on equity of 16.91 percent was realized. Twelve trailing months earnings per share reached a value of $2.31. Last fiscal year, the company paid $0.66 in form of dividends to shareholders. The stock has a short float of 6.81 percent.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 12.54, P/S ratio 1.23 and P/B ratio 2.09. Dividend Yield: 2.28 percent. The beta ratio is 0.73.






Chemed Corporation (NYSE:CHE) has a market capitalization of $1.06 billion. The company employs 13,733 people, generates revenues of $1,355.97 million and has a net income of $85.98 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $184.02 million. Because of these figures, the EBITDA margin is 13.57 percent (operating margin 11.34 percent and the net profit margin finally 6.34 percent).

Financial Analysis: The total debt representing 20.96 percent of the company’s assets and the total debt in relation to the equity amounts to 40.32 percent. Due to the financial situation, a return on equity of 19.64 percent was realized. Twelve trailing months earnings per share reached a value of $4.35. Last fiscal year, the company paid $0.60 in form of dividends to shareholders. The stock has a short float of 13.63 percent.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 12.78, P/S ratio 0.79 and P/B ratio 2.56. Dividend Yield: 1.15 percent. The beta ratio is 0.37.






Take a closer look at the full table of the most shorted healthcare dividend stocks. The average price to earnings ratio (P/E ratio) amounts to 16.92 and forward P/E ratio is 11.98. The dividend yield has a value of 2.80 percent. Price to book ratio is 3.14 and price to sales ratio 1.88. The operating margin amounts to 20.97 percent and the beta ratio is 0.86.

Here is the full table with some fundamentals (TTM):


Related stock ticker symbols:
PETS, VIVO, CHE, MR, PDLI, LNCR, WST, STE, MRX, XRAY, IVC, HLF